Pyridoxine HCl or P5P: choosing a vitamin B6 grade
Pyridoxine hydrochloride and pyridoxal 5'-phosphate are two different label ingredients, not two purities of one vitamin. One is the hydrochloride salt of pyridoxine; the other is the phosphorylated aldehyde, usually supplied as the monohydrate or a salt. They differ in molecular weight, vitamin mass, solubility and stability, and the EU and UK lists carry a separate B6 phosphate entry. The choice follows the label and the process, not the sample bag.
Pyridoxine hydrochloride and P5P are different label ingredients: the salt, the potency per milligram, the solubility and the permitted-source entry all change with the form.
Why the form is the first question
“Grade” is loose language here. Pyridoxine hydrochloride is a defined salt, CAS 58-56-0, 205.64 g/mol, with a chloride counter-ion. Pyridoxal 5'-phosphate, CAS 54-47-7, is a different molecule with a phosphate group and an aldehyde; its common commercial form is the monohydrate at 265.16 g/mol. Both deliver vitamin B6 on a panel, but they are separate substances in the ingredient list, the assay method and the source list.
The assay percentage is the first trap. A quotation for “B6 99%” can describe the hydrochloride, a P5P salt, a P5P monohydrate or a diluted blend, and those percentages have different denominators. Ask for the chemical name, the salt or hydrate and the assay basis before comparing two numbers.
The two forms side by side
| Property | Pyridoxine hydrochloride | Pyridoxal 5'-phosphate |
|---|---|---|
| Chemical name | Pyridoxine hydrochloride | Pyridoxal 5'-phosphate |
| CAS number | 58-56-0 | 54-47-7 (free acid); 41468-25-1 (monohydrate) |
| Formula and molecular weight | C8H11NO3·HCl, 205.64 g/mol | C8H10NO6P, 247.14 g/mol; monohydrate 265.16 g/mol |
| Assay convention | 99.0–101.0% on the dried basis, titration | Expressed as the phosphate form; water declared |
| Pyridoxine fraction | 82.3% of the salt mass | 68.5% of the free acid; 63.8% of the monohydrate |
| Counter-ion | Chloride, 16.9–17.6% | Phosphate; no chloride |
| Solubility in water | Freely soluble; the 5% solution is pH 2.4–3.0 | Sparingly soluble as the free acid; salt forms and alkaline pH improve it |
| Light and heat | Light-sensitive; the dry powder is durable | Light-sensitive; more labile, especially in solution |
| Ingredient-list name | Pyridoxine hydrochloride | Pyridoxine 5'-phosphate (EU/UK entry name); pyridoxal 5'-phosphate (US) |
The pyridoxine-fraction row changes the weigh-out; the counter-ion row changes the identity test. Neither is visible in a single assay percentage.
Solubility, stability and the dosage form
Pyridoxine hydrochloride dissolves freely in water and gives an acidic solution, which makes it the easier form for a liquid, a stick or a gummy. The acidity is real: a 5% solution sits at pH 2.4–3.0, so it contributes to the acid load and the taste. In a dry capsule or tablet the acidity is irrelevant, and the 40 mesh crystalline powder flows and blends well; an 80 mesh or granulated grade is available where segregation or dust is the issue.
P5P is sparingly soluble as the free acid and is usually supplied as the monohydrate or a salt. The salt brings its own counter-ion and water, both of which belong in the specification. Solubility improves in alkaline solution or with a salt form, but an alkaline matrix is a less friendly environment for the molecule.
Both forms are light-sensitive and need an opaque pack. P5P is the more labile, particularly in solution, where light, heat and water work together. A dry blend or a direct-compression tablet keeps either form in the environment it tolerates most readily; a gummy cook, a wet granulation or a drink puts the material into water and heat, and the stability data has to belong to that matrix.
Converting a label claim into a weigh-out
The label declares vitamin B6, not the salt. For the hydrochloride the conversion is the molecular-weight ratio: 10 mg of pyridoxine is 10 ÷ 0.823, or about 12.2 mg of pyridoxine hydrochloride. For P5P the same 10 mg is about 14.6 mg of the free acid, or about 15.7 mg of the monohydrate, because the phosphate group, and the water in the monohydrate, add mass that carries no pyridoxine. A form switch made at the same milligram weight therefore changes the label claim, and a switch made at the same label claim changes the weigh-out.
The reference values sit behind the percentage on the panel. In the EU and the UK the nutrient reference value for vitamin B6 is 1.4 mg, and in the US the daily value is 1.7 mg under the current labelling rule. Those figures are label references, not a dose recommendation, and they are declared in milligrams of vitamin B6. The overage is a separate decision: it comes from the loss curve of the specific form in the specific pack, so an overage carried over from the hydrochloride is not evidence for P5P.
At these masses the raw material is not the constraint: a 10 mg claim is a small fraction of a capsule fill, so blend uniformity and the premix carrier decide whether the label holds. The assay basis and water limit set the weigh-out.
What changes in the specification and the label
A form switch is a new specification. The chemical name and CAS number change, the assay method may need revalidation, and the counter-ion test changes from chloride to phosphate. The water limit changes with the hydrate, the solubility changes the process, and the stability data must be repeated in the new matrix. The label name changes with the substance, and the permitted-source entry has to match it: the EU and UK lists name pyridoxine hydrochloride and a separate phosphate entry, worded pyridoxine 5'-phosphate; confirm the P5P form matches it.
In the US the Supplement Facts panel declares vitamin B6 while the ingredient list names the form, so the two lines have to stay consistent. A product with both forms must declare both; a blend sold as one form is a labelling problem even when the total vitamin B6 is correct.
Write the specification around the substance: chemical name with salt and hydrate, CAS number, assay basis and method, counter-ion, water limit, particle size and the label name for each market. Then confirm the claim arithmetic, overage and stability data have been rebuilt around it.
When to stay with the hydrochloride
The hydrochloride is the default when the artwork is approved, the dosage form is a dry capsule or tablet, several markets have to be covered from one file, and the buyer's method covers the salt. It is also the simpler file: one counter-ion, one assay convention and an established supply chain.
P5P is the choice when the destination market permits that specific entry by name, when the formula and pack have been studied with it, and when the analytical method covers the phosphate form. Those are file conditions. A switch made before the file exists is a formula change without a label.
The direct comparison is on the HCl versus P5P page. The catalog specification is on the vitamin B6 product page; the certificate lines are on the COA page; the storage question is on the stability page; the market rules are on the compliance page. The reference values are in the NRV entry and the daily-value entry.
In this document
Related documents
Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.
Request a quotation